10/4/24 17:29 | 10/2/24 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Dube Michael P | MA | O | VP,Chief | S | -38 | 19.01 | 0 | -2 | -4 | 47 | D | | | | | | | | | | | | | | |
7/3/24 13:15 | 7/1/24 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Clark Eliana | MA | O | EVP,Chie | S | -9 | 22.93 | 0 | 0 | -1 | 71 | D | | | | | | | | | | | | | | |
6/20/24 17:00 | 6/17/24 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Verwiel Frank | MA | D | | S | -38 | 25.00 | 0 | -2 | -8 | 18 | D | | | | | | | | | | | | | | |
3/5/24 16:10 | 3/4/24 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Basta James | MA | O | EVP,GC | S.d | -76 | 32.99 | 0 | -2 | -3 | 82 | D | | | | | | | | | | | | | | |
3/5/24 16:10 | 3/4/24 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Clark Eliana | MA | O | EVP,Chie | S.d | -20 | 32.99 | 0 | -1 | -1 | 71 | D | | | | | | | | | | | | | | |
1/10/24 16:15 | 1/8/24 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Sepp-Lorenzino Laura | MA | O | EVP,Chie | S | -66 | 28.87 | 0 | -2 | -5 | 44 | D | | | | | | | | | | | | | | |
1/5/24 16:51 | 1/3/24 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | S | -566 | 29.46 | 0 | -19 | -2 | 905 | D | | | | | | | | | | | | | | |
1/5/24 16:50 | 1/3/24 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | S | -172 | 29.46 | 0 | -6 | -10 | 54 | D | | | | | | | | | | | | | | |
1/5/24 16:50 | 1/3/24 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Sepp-Lorenzino Laura | MA | O | EVP,Chie | S | -163 | 29.46 | 0 | -6 | -11 | 46 | D | | | | | | | | | | | | | | |
1/5/24 16:49 | 1/3/24 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Glenn | MA | O | EVP,CFO | S | -158 | 29.46 | 0 | -5 | -12 | 41 | D | | | | | | | | | | | | | | |
1/5/24 16:46 | 1/3/24 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Hicks Derek | MA | O | EVP,Chie | S | -114 | 29.46 | 0 | -4 | -9 | 37 | D | | | | | | | | | | | | | | |
1/5/24 16:45 | 1/3/24 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Basta James | MA | O | EVP,GC | S | -112 | 29.46 | 0 | -4 | -7 | 51 | D | | | | | | | | | | | | | | |
1/5/24 16:44 | 1/3/24 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Clark Eliana | MA | O | EVP,Chie | S | -136 | 29.50 | 0 | -5 | -10 | 41 | D | | | | | | | | | | | | | | |
1/3/24 17:35 | 1/1/24 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Sepp-Lorenzino Laura | MA | O | EVP,Chie | M.d | 0 | 0.00 | 0 | 4 | 7 | 52 | D | | | | | | | | | | | | | | |
1/3/24 17:34 | 1/1/24 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | M.d | 0 | 0.00 | 0 | 3 | 6 | 60 | D | | | | | | | | | | | | | | |
1/3/24 17:30 | 1/1/24 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 8 | 1 | 924 | D | | | | | | | | | | | | | | |
1/3/24 17:28 | 1/1/24 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Glenn | MA | O | EVP,CFO | M.d | 0 | 0.00 | 0 | 3 | 7 | 46 | D | | | | | | | | | | | | | | |
11/2/23 16:42 | 10/31/23 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Bhanji Muna | MA | D | | S | -6 | 23.90 | 0 | 0 | -2 | 12 | D | | | | | | | | | | | | | | |
8/2/23 17:19 | 7/31/23 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Bhanji Muna | MA | D | | S | -11 | 42.33 | 0 | 0 | -2 | 12 | D | | | | | | | | | | | | | | |
7/10/23 17:21 | 7/6/23 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Bhanji Muna | MA | D | | S | -73 | 39.30 | 0 | -2 | -13 | 13 | D | | | | | | | | | | | | | | |
7/6/23 15:34 | 7/3/23 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Clark Eliana | MA | O | EVP,Chie | S | -15 | 40.51 | 0 | 0 | -1 | 45 | D | | | | | | | | | | | | | | |
6/22/23 17:52 | 6/20/23 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Clark Eliana | MA | O | EVP,Chie | M.d | 61 | 12.27 | 0 | 5 | 12 | 45 | D | | | | | | | | | | | | | | |
6/22/23 17:52 | 6/20/23 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Clark Eliana | MA | O | EVP,Chie | S.d | -225 | 45.00 | 0 | -5 | -10 | 45 | D | | | | | | | | | | | | | | |
3/3/23 17:10 | 3/2/23 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Basta James | MA | O | EVP,GC | S.d | -48 | 43.88 | 0 | -1 | -2 | 55 | D | | | | | | | | | | | | | | |
1/6/23 17:39 | 1/4/23 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Sepp-Lorenzino Laura | MA | O | EVP,Chie | S.m | -183 | 37.82 | 0 | -5 | -22 | 18 | D | | | | | | | | | | | | | | |
1/6/23 17:32 | 1/4/23 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | S | -248 | 37.21 | 0 | -7 | -1 | 825 | D | | | | | | | | | | | | | | |
1/6/23 17:29 | 1/4/23 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Hicks Derek | MA | O | EVP,Chie | S | -67 | 37.21 | 0 | -2 | -9 | 17 | D | | | | | | | | | | | | | | |
1/6/23 17:26 | 1/4/23 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | S | -96 | 37.21 | 0 | -3 | -9 | 26 | D | | | | | | | | | | | | | | |
1/6/23 17:23 | 1/4/23 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Glenn | MA | O | EVP,CFO | S | -90 | 37.21 | 0 | -2 | -14 | 15 | D | | | | | | | | | | | | | | |
1/6/23 17:21 | 7/1/22 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Clark Eliana | MA | O | EVP,Chie | S.m | -76 | 37.65 | 0 | -2 | -12 | 14 | D | | | | | | | | | | | | | | |
1/6/23 17:19 | 1/4/23 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Basta James | MA | O | EVP,GC | S | -42 | 37.21 | 0 | -1 | -5 | 20 | D | | | | | | | | | | | | | | |
1/4/23 20:38 | 1/1/23 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Sepp-Lorenzino Laura | MA | O | EVP,Chie | M.d | 0 | 0.00 | 0 | 4 | 18 | 22 | D | | | | | | | | | | | | | | |
1/4/23 20:36 | 1/1/23 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 8 | 1 | 832 | D | | | | | | | | | | | | | | |
1/4/23 20:33 | 1/1/23 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | M.d | 0 | 0.00 | 0 | 3 | 13 | 28 | D | | | | | | | | | | | | | | |
1/4/23 20:29 | 1/1/23 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Glenn | MA | O | EVP,CFO | M.d | 0 | 0.00 | 0 | 3 | 21 | 18 | D | | | | | | | | | | | | | | |
3/4/22 21:07 | 1/1/22 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 8 | 1 | 824 | D | | | | | | | | | | | | | | |
3/4/22 21:07 | 1/1/22 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | S.d | -280 | 112.26 | 0 | -2 | 0 | 824 | D | | | | | | | | | | | | | | |
3/3/22 20:03 | 1/1/22 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Sepp-Lorenzino Laura | MA | O | EVP,Chie | M.d | 0 | 0.00 | 0 | 4 | 23 | 19 | D | | | | | | | | | | | | | | |
3/3/22 20:03 | 1/1/22 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Sepp-Lorenzino Laura | MA | O | EVP,Chie | S.d | -129 | 112.25 | 0 | -1 | -6 | 19 | D | | | | | | | | | | | | | | |
3/3/22 20:00 | 1/1/22 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | M.d | 0 | 0.00 | 0 | 3 | 15 | 25 | D | | | | | | | | | | | | | | |
3/3/22 20:00 | 1/1/22 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | S.d | -118 | 112.24 | 0 | -1 | -4 | 25 | D | | | | | | | | | | | | | | |
3/3/22 19:38 | 1/1/22 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Glenn | MA | O | EVP,CFO | M.d | 0 | 0.00 | 0 | 3 | 26 | 15 | D | | | | | | | | | | | | | | |
3/3/22 19:38 | 1/1/22 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Glenn | MA | O | EVP,CFO | S.d | -114 | 112.24 | 0 | -1 | -6 | 15 | D | | | | | | | | | | | | | | |
11/9/21 18:08 | 11/5/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | M.d | 30 | 12.62 | 0 | 2 | 38 | 9 | D | | | | | | | | | | | | | | |
11/9/21 18:08 | 11/5/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | S.d | -319 | 132.72 | 0 | -2 | -22 | 9 | D | | | | | | | | | | | | | | |
10/15/21 19:02 | 10/14/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | M.d | 30 | 12.62 | 0 | 2 | 38 | 9 | D | | | | | | | | | | | | | | |
10/15/21 19:02 | 10/14/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | S.d | -308 | 128.44 | 0 | -2 | -22 | 9 | D | | | | | | | | | | | | | | |
10/13/21 16:15 | 10/11/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Crowley John F | MA | D | | M.d | 47 | 18.83 | 0 | 3 | | 2 | D | | | | | | | | | | | | | | |
10/13/21 16:15 | 10/11/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Crowley John F | MA | D | | S.d | -299 | 119.55 | 0 | -3 | -54 | 2 | D | | | | | | | | | | | | | | |
10/7/21 17:41 | 10/5/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Crowley John F | MA | D | | M.d | 188 | 18.83 | 0 | 10 | | 2 | D | | | | | | | | | | | | | | |
10/7/21 17:41 | 10/5/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Crowley John F | MA | D | | S.d | -1,305 | 130.54 | 0 | -10 | -83 | 2 | D | | | | | | | | | | | | | | |
9/27/21 16:15 | 9/24/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | M.d | 100 | 12.62 | 0 | 8 | 999% | 9 | D | | | | | | | | | | | | | | |
9/23/21 17:48 | 9/21/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | M.d | 30 | 12.62 | 0 | 2 | | 1 | D | | | | | | | | | | | | | | |
9/23/21 17:48 | 9/21/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | S.d | -360 | 149.81 | 0 | -2 | -75 | 1 | D | | | | | | | | | | | | | | |
9/9/21 17:38 | 9/7/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Glenn | MA | O | EVP,CFO | M.d | 51 | 14.58 | 0 | 3 | | 0 | D | | | | | | | | | | | | | | |
9/9/21 17:38 | 9/7/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Glenn | MA | O | EVP,CFO | S.d | -627 | 180.12 | 0 | -3 | -100 | 0 | D | | | | | | | | | | | | | | |
9/1/21 20:21 | 8/30/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | M.dm | 2,071 | 17.06 | 0 | 121 | 18 | 778 | D | | | | | | | | | | | | | | |
9/1/21 20:21 | 8/30/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | S.dm | -19,520 | 160.83 | 0 | -121 | -13 | 778 | D | | | | | | | | | | | | | | |
9/1/21 19:34 | 8/30/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Sepp-Lorenzino Laura | MA | O | EVP,Chie | M.d | 1,359 | 14.01 | 0 | 97 | | 2 | D | | | | | | | | | | | | | | |
9/1/21 19:34 | 8/30/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Sepp-Lorenzino Laura | MA | O | EVP,Chie | S.d | -15,018 | 154.83 | 0 | -97 | -98 | 2 | D | | | | | | | | | | | | | | |
9/1/21 19:32 | 8/30/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | M.d | 30 | 12.62 | 0 | 2 | | 1 | D | | | | | | | | | | | | | | |
9/1/21 19:32 | 8/30/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | S.d | -379 | 158.04 | 0 | -2 | -75 | 1 | D | | | | | | | | | | | | | | |
9/1/21 19:30 | 8/30/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Glenn | MA | O | EVP,CFO | M.dm | 570 | 18.99 | 0 | 30 | | 0 | D | | | | | | | | | | | | | | |
9/1/21 19:30 | 8/30/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Glenn | MA | O | EVP,CFO | S.dm | -4,784 | 159.45 | 0 | -30 | -100 | 0 | D | | | | | | | | | | | | | | |
8/25/21 16:14 | 8/23/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | M.d | 364 | 13.40 | 0 | 27 | 4 | 778 | D | | | | | | | | | | | | | | |
8/25/21 16:14 | 8/23/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | S.d | -4,125 | 152.01 | 0 | -27 | -3 | 778 | D | | | | | | | | | | | | | | |
8/20/21 18:14 | 8/19/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | M.d | 304 | 13.40 | 0 | 23 | 3 | 778 | D | | | | | | | | | | | | | | |
8/20/21 18:14 | 8/19/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | S.d | -3,431 | 151.28 | 0 | -23 | -3 | 778 | D | | | | | | | | | | | | | | |
8/11/21 16:50 | 8/9/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | M.d | 30 | 12.62 | 0 | 2 | | 1 | D | | | | | | | | | | | | | | |
8/11/21 16:50 | 8/9/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | S.d | -394 | 164.05 | 0 | -2 | -75 | 1 | D | | | | | | | | | | | | | | |
8/6/21 18:19 | 8/4/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Sepp-Lorenzino Laura | MA | O | EVP,Chie | M.d | 348 | 13.40 | 0 | 26 | | 2 | D | | | | | | | | | | | | | | |
8/6/21 18:19 | 8/4/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Sepp-Lorenzino Laura | MA | O | EVP,Chie | S.d | -3,594 | 138.24 | 0 | -26 | -92 | 2 | D | | | | | | | | | | | | | | |
8/6/21 18:17 | 8/5/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Glenn | MA | O | EVP,CFO | M.d | 385 | 19.27 | 0 | 20 | | 0 | D | | | | | | | | | | | | | | |
8/6/21 18:17 | 8/5/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Glenn | MA | O | EVP,CFO | S.d | -3,021 | 151.05 | 0 | -20 | -100 | 0 | D | | | | | | | | | | | | | | |
6/29/21 09:48 | 6/28/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Formela Jean Francois | MA | D | | S | -73,449 | 132.73 | 0 | -553 | -98 | 10 | I | | | | | | | | | | | | | | |
6/15/21 09:51 | 6/11/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Formela Jean Francois | MA | D | | S.m | -17,559 | 87.04 | 0 | -202 | -15 | 1,127 | I | | | | | | | | | | | | | | |
4/30/21 20:55 | 4/29/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Formela Jean Francois | MA | D | | S | -386 | 85.43 | 0 | -5 | -1 | 765 | I | | | | | | | | | | | | | | |
4/28/21 19:51 | 4/26/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Formela Jean Francois | MA | D | | S.m | -29,482 | 85.96 | 0 | -343 | -31 | 770 | I | | | | | | | | | | | | | | |
4/15/21 20:50 | 4/13/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | M.d | 290 | 11.16 | 0 | 26 | 3 | 778 | D | | | | | | | | | | | | | | |
4/7/21 14:14 | 4/5/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Formela Jean Francois | MA | D | | S | -68 | 84.98 | 0 | -1 | 0 | 1,113 | I | | | | | | | | | | | | | | |
4/6/21 18:09 | 4/5/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Dorsa Caroline | MA | D | | M.d | 48 | 6.40 | 0 | 8 | | 5 | D | | | | | | | | | | | | | | |
4/6/21 18:09 | 4/5/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Dorsa Caroline | MA | D | | S.d | -616 | 82.19 | 0 | -8 | -58 | 5 | D | | | | | | | | | | | | | | |
4/2/21 20:46 | 4/1/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | M.d | 1,005 | 14.15 | 0 | 71 | 10 | 752 | D | | | | | | | | | | | | | | |
4/2/21 20:46 | 4/1/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | S.d | -3,196 | 83.64 | 0 | -38 | -5 | 752 | D | | | | | | | | | | | | | | |
4/2/21 20:42 | 4/1/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | M.d | 1,214 | 12.51 | 0 | 97 | 30 | 425 | D | | | | | | | | | | | | | | |
4/2/21 20:42 | 4/1/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | S.d | -4,161 | 82.46 | 0 | -50 | -11 | 425 | D | | | | | | | | | | | | | | |
3/1/21 13:59 | 2/26/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Formela Jean Francois | MA | D | | S | -30,263 | 60.29 | 0 | -502 | -31 | 1,113 | I | | | | | | | | | | | | | | |
2/9/21 20:38 | 2/9/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | M.d | 384 | 18.30 | 0 | 21 | 6 | 380 | D | | | | | | | | | | | | | | |
2/9/21 20:38 | 2/9/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | S.d | -862 | 75.00 | 0 | -11 | -3 | 380 | D | | | | | | | | | | | | | | |
2/9/21 20:36 | 2/5/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | M.dm | 923 | 9.55 | 0 | 97 | 16 | 719 | D | | | | | | | | | | | | | | |
2/9/21 20:36 | 2/5/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | S.dm | -3,655 | 71.70 | 0 | -51 | -7 | 719 | D | | | | | | | | | | | | | | |
2/3/21 21:39 | 2/1/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | M.dm | 4,807 | 15.16 | 0 | 317 | 89 | 673 | D | | | | | | | | | | | | | | |
2/3/21 21:39 | 2/1/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | S.dm | -11,955 | 67.26 | 0 | -178 | -21 | 673 | D | | | | | | | | | | | | | | |
2/3/21 21:38 | 2/1/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | M.d | 1,055 | 9.68 | 0 | 109 | 42 | 371 | D | | | | | | | | | | | | | | |
2/3/21 21:38 | 2/1/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | S.d | -3,498 | 64.00 | 0 | -55 | -13 | 371 | D | | | | | | | | | | | | | | |
1/22/21 16:22 | 1/20/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Cohen Fred E | MA | D | | M.d | 276 | 13.78 | 0 | 20 | 200 | 30 | D | | | | | | | | | | | | | | |
1/5/21 21:24 | 12/31/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 14 | 3 | 534 | D | | | | | | | | | | | | | | |
1/5/21 21:24 | 1/5/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | S.d | -349 | 55.86 | 0 | -6 | -1 | 534 | D | | | | | | | | | | | | | | |
1/5/21 20:58 | 12/31/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Schiermeier Andrew | MA | O | EVP,COO | M.d | 0 | 0.00 | 0 | 5 | 40 | 17 | D | | | | | | | | | | | | | | |
1/5/21 20:58 | 1/5/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Schiermeier Andrew | MA | O | EVP,COO | S.d | -77 | 55.86 | 0 | -1 | -8 | 17 | D | | | | | | | | | | | | | | |
1/5/21 20:55 | 12/31/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | M.d | 0 | 0.00 | 0 | 5 | 2 | 314 | D | | | | | | | | | | | | | | |
1/5/21 20:55 | 1/5/21 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | S.d | -116 | 55.86 | 0 | -2 | -1 | 314 | D | | | | | | | | | | | | | | |
1/4/21 21:03 | 12/30/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Schiermeier Andrew | MA | O | EVP,COO | M.d | 20 | 13.48 | 0 | 2 | 13 | 13 | D | | | | | | | | | | | | | | |
12/18/20 16:29 | 12/17/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Karsen Perry A | MA | D | | M.d | 1,638 | 18.45 | 0 | 89 | | 5 | D | | | | | | | | | | | | | | |
12/18/20 16:29 | 12/17/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Karsen Perry A | MA | D | | S.d | -4,754 | 53.55 | 0 | -89 | -95 | 5 | D | | | | | | | | | | | | | | |
12/3/20 18:42 | 12/1/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | M.d | 69 | 13.88 | 0 | 5 | 2 | 311 | D | | | | | | | | | | | | | | |
12/3/20 18:42 | 12/1/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | S.d | -129 | 38.21 | 0 | -3 | -1 | 311 | D | | | | | | | | | | | | | | |
11/27/20 21:00 | 11/27/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | M.d | 566 | 16.17 | 0 | 35 | 7 | 526 | D | | | | | | | | | | | | | | |
11/27/20 21:00 | 11/27/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | S.d | -1,350 | 38.57 | 0 | -35 | -6 | 526 | D | | | | | | | | | | | | | | |
11/25/20 20:02 | 11/25/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | M.d | 342 | 6.83 | 0 | 50 | 11 | 526 | D | | | | | | | | | | | | | | |
11/25/20 20:02 | 11/25/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | S.d | -1,800 | 36.00 | 0 | -50 | -9 | 526 | D | | | | | | | | | | | | | | |
11/18/20 19:56 | 11/16/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | M.d | 292 | 14.58 | 0 | 20 | 4 | 526 | D | | | | | | | | | | | | | | |
11/18/20 19:56 | 11/16/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | S.d | -680 | 34.00 | 0 | -20 | -4 | 526 | D | | | | | | | | | | | | | | |
11/18/20 19:55 | 11/16/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | M.dm | 94 | 8.25 | 0 | 11 | 4 | 309 | D | | | | | | | | | | | | | | |
11/18/20 19:55 | 11/16/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | S.dm | -229 | 34.36 | 0 | -7 | -2 | 309 | D | | | | | | | | | | | | | | |
11/6/20 16:41 | 11/4/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | M.d | 69 | 13.88 | 0 | 5 | 2 | 305 | D | | | | | | | | | | | | | | |
11/6/20 16:41 | 11/4/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | S.d | -94 | 28.00 | 0 | -3 | -1 | 305 | D | | | | | | | | | | | | | | |
11/6/20 16:38 | 11/4/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | M.d | 342 | 6.83 | 0 | 50 | 11 | 526 | D | | | | | | | | | | | | | | |
11/6/20 16:38 | 11/4/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | S.d | -1,300 | 26.00 | 0 | -50 | -9 | 526 | D | | | | | | | | | | | | | | |
10/16/20 20:58 | 10/15/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | M.d | 68 | 6.83 | 0 | 10 | 3 | 303 | D | | | | | | | | | | | | | | |
10/16/20 20:58 | 10/15/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | S.d | -136 | 24.20 | 0 | -6 | -2 | 303 | D | | | | | | | | | | | | | | |
10/9/20 16:14 | 10/7/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | M.d | 34 | 6.83 | 0 | 5 | 1 | 526 | D | | | | | | | | | | | | | | |
10/9/20 16:14 | 10/7/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | S.d | -109 | 21.83 | 0 | -5 | -1 | 526 | D | | | | | | | | | | | | | | |
9/17/20 16:55 | 9/15/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | M.d | 68 | 6.83 | 0 | 10 | 3 | 299 | D | | | | | | | | | | | | | | |
9/17/20 16:55 | 9/15/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | S.d | -118 | 21.04 | 0 | -6 | -2 | 299 | D | | | | | | | | | | | | | | |
9/3/20 16:15 | 9/1/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M. | MA | DO | P,CEO | M.d | 34 | 6.83 | 0 | 5 | 1 | 526 | D | | | | | | | | | | | | | | |
9/3/20 16:15 | 9/1/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M. | MA | DO | P,CEO | S.d | -109 | 21.83 | 0 | -5 | -1 | 526 | D | | | | | | | | | | | | | | |
8/20/20 16:13 | 8/18/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | M.d | 68 | 6.83 | 0 | 10 | 4 | 294 | D | | | | | | | | | | | | | | |
8/20/20 16:13 | 8/18/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | S.d | -118 | 21.00 | 0 | -6 | -2 | 294 | D | | | | | | | | | | | | | | |
8/7/20 19:29 | 8/6/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M. | MA | DO | P,CEO | M.d | 34 | 6.83 | 0 | 5 | 1 | 526 | D | | | | | | | | | | | | | | |
8/7/20 19:29 | 8/6/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M. | MA | DO | P,CEO | S.d | -109 | 21.83 | 0 | -5 | -1 | 526 | D | | | | | | | | | | | | | | |
7/17/20 16:18 | 7/15/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | M.d | 68 | 6.83 | 0 | 10 | 4 | 290 | D | | | | | | | | | | | | | | |
7/17/20 16:18 | 7/15/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | S.d | -127 | 22.70 | 0 | -6 | -2 | 290 | D | | | | | | | | | | | | | | |
7/2/20 16:10 | 7/1/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M. | MA | DO | P,CEO | M.d | 34 | 6.83 | 0 | 5 | 1 | 526 | D | | | | | | | | | | | | | | |
7/2/20 16:10 | 7/1/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M. | MA | DO | P,CEO | S.d | -109 | 21.83 | 0 | -5 | -1 | 526 | D | | | | | | | | | | | | | | |
6/18/20 17:00 | 6/16/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | M.d | 68 | 6.83 | 0 | 10 | 4 | 284 | D | | | | | | | | | | | | | | |
6/18/20 17:00 | 6/16/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | S.d | -118 | 21.00 | 0 | -6 | -2 | 284 | D | | | | | | | | | | | | | | |
6/5/20 17:18 | 6/3/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M. | MA | DO | P,CEO | M.d | 34 | 6.83 | 0 | 5 | 1 | 526 | D | | | | | | | | | | | | | | |
6/5/20 17:18 | 6/3/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M. | MA | DO | P,CEO | S.d | -109 | 21.83 | 0 | -5 | -1 | 526 | D | | | | | | | | | | | | | | |
5/28/20 17:23 | 5/26/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | M.d | 68 | 6.83 | 0 | 10 | 4 | 280 | D | | | | | | | | | | | | | | |
5/28/20 17:23 | 5/26/20 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | S.d | -119 | 21.21 | 0 | -6 | -2 | 280 | D | | | | | | | | | | | | | | |
3/12/19 16:38 | 3/6/19 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Schiermeier Andrew | MA | O | EVP,Dev, | P | 118 | 15.72 | 0 | 8 | 87 | 16 | D | | | | | | | | | | | | | | |
7/18/18 08:40 | 7/16/18 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Formela Jean Francois | MA | D | | S | -208 | 31.17 | 0 | -7 | 0 | 1,615 | I | | | | | | | | | | | | | | |
6/20/18 12:03 | 6/19/18 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Formela Jean Francois | MA | D | | S | -187 | 27.96 | 0 | -7 | 0 | 1,837 | I | | | | | | | | | | | | | | |
5/17/18 10:47 | 5/16/18 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Formela Jean Francois | MA | D | | S | -167 | 25.04 | 0 | -7 | 0 | 2,058 | I | | | | | | | | | | | | | | |
5/15/18 20:43 | 5/14/18 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M. | MA | DO | P,CEO | S | -202 | 24.00 | 0 | -8 | -2 | 526 | I | | | | | | | | | | | | | | |
3/30/18 10:20 | 3/28/18 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Bell Graeme | MA | O | EVP,CFO | M.d | 108 | 13.48 | 0 | 8 | 60 | 21 | D | | | | | | | | | | | | | | |
3/22/18 13:43 | 3/20/18 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Formela Jean Francois | MA | D | | S | -937 | 23.87 | 0 | -39 | -2 | 2,280 | I | | | | | | | | | | | | | | |
1/30/18 17:28 | 1/29/18 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Caribou Biosciences, Inc. | CA | T | | S | -14,746 | 26.78 | 0 | -551 | -12 | 3,994 | I | | | | | | | | | | | | | | |
12/14/17 12:19 | 12/12/17 | NTLA | Health | Drug | Pharmaceutical Preparations | Novartis Institutes For Biomedical Research, Inc. | MA | T | | S | -27,871 | 18.30 | 0 | -1,523 | -27 | 4,130 | D | | | | | | | | | | | | | | |
12/8/17 17:27 | 12/6/17 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Bermingham Nessan | MA | DO | P,CEO | S.m | -7,000 | 20.79 | 0 | -337 | -42 | 458 | D | | | | | | | | | | | | | | |
9/13/17 18:29 | 9/13/17 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Caribou Biosciences, Inc. | CA | T | | S | 0 | 0.00 | 0 | -1,049 | -19 | 4,545 | I | | | | | | | | | | | | | | |
7/11/17 17:40 | 7/7/17 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Formela Jean Francois | MA | D | | S.m | -2,435 | 16.24 | 0 | -150 | -4 | 3,580 | I | | | | | | | | | | | | | | |
7/11/17 17:37 | 7/7/17 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Atlas Venture Fund Ix, L.P. | MA | T | | S.m | -2,435 | 16.24 | 0 | -150 | -4 | 3,580 | D | | | | | | | | | | | | | | |
3/13/17 10:39 | 3/9/17 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Atlas Venture Associates Ix, L.P. | MA | T | | S.m | -294 | 13.91 | 4 | -21 | -1 | 3,730 | D | | | -35 | -8 | 12 | 4 | -6 | 8 | 1 | 2 | -3 | | | |
3/13/17 10:34 | 3/9/17 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Formela Jean Francois | MA | D | | S.m | -294 | 13.91 | 4 | -21 | -1 | 3,730 | I | | | -35 | -8 | 12 | 4 | -6 | 8 | 1 | 2 | -3 | | | |
5/13/16 16:58 | 5/11/16 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Orbimed Advisors LLC | NY | D | | P.d | 4,500 | 18.00 | 33 | 250 | 10 | 2,662 | I | | | | | | | | -2 | 7 | 13 | 14 | -23 | -38 | |
5/13/16 06:15 | 5/11/16 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Temasek Holdings (Private) Ltd | U0 | T | | P.d | 5,400 | 18.00 | 33 | 300 | 31 | 1,281 | I | | | | | | | | -2 | -1 | 13 | 13 | -24 | -39 | |
5/11/16 18:57 | 5/11/16 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Novartis Institutes For Biomedical Research, Inc. | MA | T | | P.d | 5,000 | 18.00 | 33 | 278 | 5 | 5,574 | D | | | | | | | | | -7 | 4 | 7 | -25 | -41 | |
5/11/16 18:36 | 5/11/16 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Gordon Carl L | MA | D | | P.d | 4,500 | 18.00 | 33 | 250 | 10 | 2,662 | I | | | | | | | | | -7 | 4 | 7 | -25 | -41 | |
5/11/16 16:25 | 5/11/16 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Baker Bros. Advisors LP | NY | H | Former 1 | P.d | 3,600 | 18.00 | 33 | 200 | 26 | 976 | I | | | | | | | | | -7 | 4 | 7 | -25 | -41 | |